The relationship between US heroin market dynamics and heroin-related overdose, 1992-2008

Addiction

Volumn 109, Issue 11, 2014, Pages 1889-1898

  Unick, George ^a   Rosenblum, Daniel ^b   Mars, Sarah ^c   Ciccarone, Daniel ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heroin; Heroin distribution; Heroin overdose; Heroin type; Structural environmental risk

Indexed keywords

DIAMORPHINE;

ADULT; CHEMISTRY; COMMERCIAL PHENOMENA; DRUG OVERDOSE; ECONOMICS; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADULT; COMMERCE; DRUG OVERDOSE; FEMALE; HEROIN; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84908024802     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12664     Document Type: Article

References (45)

1. Backmund M., Schuetz C., Meyer K., Edlin B. R., Reimer J. The risk of emergency room treatment due to overdose in injection drug users. J Addict Dis 2009; 28: 68-73.
2. Darke S., Farrell M. Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment. Addiction 2014; 109: 1237-1242.
3. Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M. etal. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011; 106: 32-51.
4. Evans J. L., Tsui J. I., Hahn J. A., Davidson P. J., Lum P. J., Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol 2012; 175: 302-308.
5. Scott G., Thomas S. D., Pollack H. A., Ray B. Observed patterns of illicit opiate overdose deaths in Chicago, 1999-2003. J Urban Health 2007; 84: 292-306.
6. Brugal M. T., Barrio G., Fuente L. D. L., Regidor E., Royuela L., Suelves J. M. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction 2002; 97: 319-327.
7. Sporer K. A. Acute heroin overdose. Ann Intern Med 1999; 130: 584-590.
8. Coffin P. O., Galea S., Ahern J., Leon A. C., Vlahov D., Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction 2003; 98: 739-747.
9. Jenkins L. M., Banta-Green C. J., Maynard C., Kingston S., Hanrahan M., Merrill J. O. etal. Risk factors for nonfatal overdose at Seattle-area syringe exchanges. J Urban Health 2011; 88: 118-128.
10. Vlahov D., Wang C., Ompad D., Fuller C. M., Caceres W., Ouellet L. etal. Mortality risk among recent-onset injection drug users in five US cities. Subst Use Misuse 2008; 43: 413-428.
11. Clausen T., Waal H., Thoresen M., Gossop M. Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction 2009; 104: 1356-1362.
12. Galea S., Ahern J., Tardiff K., Leon A., Coffin P. O., Derr K. etal. Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998. J Urban Health 2003; 80: 201-211.
13. Marzuk P. M., Tardiff K., Leon A. C., Hirsch C. S., Stajic M., Portera L. etal. Poverty and fatal accidental drug overdoses of cocaine and opiates in New York City: an ecological study. Am J Drug Alcohol Abuse 1997; 23: 221-228.
14. Williams C. T., Latkin C. A. Neighborhood socioeconomic status, personal network attributes, and use of heroin and cocaine. Am J Prev Med 2007; 32: S203-210.
15. Seal K. H., Kral A. H., Gee L., Moore L. D., Bluthenthal R. N., Lorvick J. etal. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health 2001; 91: 1842-1846.
16. Bohnert A. S. B., Nandi A., Tracy M., Cerdá M., Tardiff K. J., Vlahov D. etal. Policing and risk of overdose mortality in urban neighborhoods. Drug Alcohol Depend 2011; 113: 62-68.
17. Davidson P. J. Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention. J Urban Health 2003; 80: 261-273.
18. Morgan O., Griffiths C. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004. Int J Epidemiol 2006; 35: 1579-1585.
19. Unick G. J., Rosenblum D., Mars S., Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLOS ONE 2013; 8: e54496.
20. Enteen L., Bauer J., McLean R., Wheeler E., Huriaux E., Kral A. H. etal. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010; 87: 931-941.
21. Dave D. The effects of cocaine and heroin price on drug-related emergency department visits. J Health Econ 2006; 25: 311-333.
22. Darke S., Hall W., Weatherburn D., Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend 1999; 54: 155-161.
23. Caulkins J. P. Drug prices and emergency department mentions for cocaine and heroin. Am J Public Health 2001; 91: 1446-1448.
24. Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. Int J Drug Policy 2009; 20: 277-282.
25. Chaloupka F., Pacula R. Economics and antihealth behavior: the economic analysis of substance use and abuse. In: Bickel W., Vuchinich R., editors. Reframing Health Behavior Change With Behavioral Economics. Hillsdale, NJ: Lawrence Erlbaum Associates; 2000, pp. 89-111.
26. Schwartz R. P., Gryczynski J., O'Grady K. E., Sharfstein J. M., Warren G., Olsen Y. etal. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. Am J Public Health 2013; 103: 917-922.
27. Darke S., Hall W. Heroin overdose: research and evidence-based intervention. J Urban Health 2003; 80: 189-200.
28. Ruttenber A. J., Luke J. L. Heroin-related deaths: new epidemiologic insights. Science 1984; 226: 14-20.
29. Ciccarone D., Unick G. J., Kraus A. Impact of South American heroin on the US heroin market 1993-2004. Int J Drug Policy 2009; 20: 392-401.
30. Office of Management and Budget. 2010 standards for delineating metropolitan and micropolitan statistical areas. Fed Regist 2010; 75: 37246-39052.
31. Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP). Introduction to the HCUP Nationwide Inpatient Sample (NIS). Rockville, MD: Agency for Healthcare Research and Quality; 2008.
32. Caulkins J. P. Price and purity analysis for illicit drug: data and conceptual issues. Drug Alcohol Depend 2007; 90: S61-68.
33. Toske S. G., Cooper S. D., Morello D. R., Hays P. A., Casale J. F., Casale E. Neutral heroin impurities from tetrahydrobenzylisoquinoline alkaloids. J Forensic Sci 2006; 51: 308-320.
34. Office of Drug Control Policy. Drug Availability Estimates in the United States, 2001-2006. Washington, DC: Executive Office of the President; 2012.
35. Rabe-Hesketh S., Skrondal A. Multilevel and longitudinal modeling using Stata. College Station, TX: StataCorp LP; 2013.
36. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2013.
37. Rosenblum D., Unick G. J., Ciccarone D. The entry of Colombian-sourced heroin into the US market: the relationship between competition, price, and purity. Int J Drug Policy 2014; 25: 88-95.
38. Mars S. G., Bourgois P., Karandinos G., Montero F., Ciccarone D. 'Every "never" I ever said came true': transitions from opioid pills to heroin injecting. Int J Drug Policy 2014; doi: 10.1016/j.drugpo.2013.10.004 [Epub ahead of print]
39. Jones C. M. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug Alcohol Depend 2013; 132: 95-100.
40. Rosenblum D., Castrillo F. M., Bourgois P., Mars S., Karandinos G., Unick G. J. etal. Urban segregation and the US heroin market: a quantitative model of anthropological hypotheses from an inner-city drug market. Int J Drug Policy 2013; 25: 543-555.
41. Coomber R. The cutting of heroin in the United States in the 1990s. J Drug Issues 1999; 29: 17-36.
42. Algren D. A., Monteilh C. P., Punja M., Schier J. G., Belson M., Hepler B. R. etal. Fentanyl-associated fatalities among illicit drug users in Wayne County, Michigan (July 2005-May 2006). J Med Toxicol 2013; 9: 106-115.
43. Jynxies. Jynxies Natural Habitat. 2013. Available at: http://dequinceyjynxie.blogspot.com (accessed 21 July 2013) (Archived at http://www.webcitation.org/6QvAaAmk9 on 8 July 2014).
44. Horowitz J. L. Should the DEA's STRIDE data be used for economic analyses of markets for illegal drugs? J Am Stat Assoc 2001; 96: 1254-1271.
45. Landen M. G., Castle S., Nolte K. B., Gonzales M., Escobedo L. G., Chatterjee B. F. etal. Methodological issues in the surveillance of poisoning, illicit drug overdose, and heroin overdose deaths in New Mexico. Am J Epidemiol 2003; 157: 273-278.